Search for: "MYLAN, INC."
Results 561 - 580
of 674
Sorted by Relevance
|
Sort by Date
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
23 Mar 2007, 1:07 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
15 Feb 2021, 1:00 am
MyLan[5]), in particular in FRAND cases? [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
12 May 2015, 2:43 pm
Steel Corp. 06366QH75 Bank of Montreal Reverse Exchangeable Notes linked to Alcoa, Inc. 06366QH91 Bank of Montreal Reverse Exchangeable Notes linked to Delta Air Lines, Inc. 06366QJ24 Bank of Montreal Reverse Exchangeable Notes linked to Dow Chemical Company 06366QJ73 Bank of Montreal Reverse Exchangeable Notes linked to Las Vegas Sands Corp. 06366QJ81 Bank of Montreal Reverse Exchangeable Notes linked to MercadoLibre Inc 06366QJ99 Bank of Montreal Reverse Exchangeable… [read post]
17 Feb 2010, 5:10 am
Trigen Laboratories, Inc (Patent Docs) Tramadol – France: Preliminary injunctions in case of an ‘imminent infringement’: Mylan v Medochemie (EPLAW) [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
15 Sep 2016, 4:00 am
Dispill Inc., 2013 FC 1043. [read post]
8 May 2019, 7:14 am
” It’s not enough to put an unapproved drug on the market with a FDA-ish package insert, according to Mylan Labs., Inc. v. [read post]
9 Jan 2018, 4:43 pm
See Garmin Int’l, Inc. v. [read post]
22 May 2015, 10:38 am
Shortly afterwards, the injunction on Krka was lifted.The declaration of non-infringement awarded to Ranbaxy opened the door to the marketing of generic esomeprazole products by a series of other companies, including Arrow, Mylan and Teva. [read post]
5 Nov 2015, 6:00 am
Mylan Pharmaceuticals Inc. v. [read post]
12 Oct 2018, 1:24 pm
Mylan Pharmaceuticals Inc., Nos.17-1594, 17-1595, 17-1596 (Fed. [read post]
25 Jan 2007, 12:48 am
Friedlander, 103 F.3d 1105, 1113 (2d Cir. 1997); Mylan Laboratories, Inc. v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
12 Mar 2018, 2:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
